Organigram Global Inc Stock Price, News & Analysis

Organigram Global (NASDAQ: OGI) has released a landmark report revealing the substantial economic impact of Canada's legal cannabis industry in 2024. The study, conducted with the Canadian Chamber of Commerce's Business Data Lab, shows that the sector contributed $16 billion to national GDP and generated $29 billion in total economic output.

The cannabis industry directly contributed $8.4 billion to GDP, surpassing traditional sectors like forestry, breweries, and wineries. It supported 227,000 jobs, including 168,000 direct positions in cultivation and retail. The sector generated $2.7 billion in farm cash receipts, outperforming greenhouse and field vegetables.

CEO Beena Goldenberg emphasized the industry's alignment with Prime Minister Carney's One Canadian Economy vision, while noting that outdated policy frameworks and tax structures are limiting the sector's growth potential in the projected CAD $140 billion international market by 2026.

Organigram (NASDAQ: OGI) reported record Q3 Fiscal 2025 results with net revenue reaching $70.8 million, up 72% year-over-year. The company achieved $5.7 million in Adjusted EBITDA (+64% YoY) and $5.0 million in Free Cash Flow.

Key highlights include international revenue of $7.4 million (+208% YoY), Motif synergies of $4.2 million to date, and a strong cash position of $85.9 million with negligible debt. The company maintains its #1 market share position in Canada across multiple categories including vapes, pre-rolls, milled flower, and concentrates.

The company expanded its U.S. presence through hemp-derived THC beverages and launched new products in the Canadian market while achieving a record Moncton harvest of 24,210 kilograms with average THC potency exceeding 29%.

Organigram (NASDAQ: OGI) (TSX: OGI), Canada's leading cannabis company by market share, has scheduled its third quarter fiscal 2025 earnings release for August 13, 2025, before market open.

The company will host a conference call at 8:00 am Eastern Time on the same day to discuss the results. Participants must register in advance through the provided link to receive dial-in details. A webcast option is also available, and a replay will be accessible for 90 days on Organigram's investor relations website.

Organigram Global (NASDAQ: OGI), Canada's leading cannabis company by market share, has launched its Collective Project e-commerce platform across 25 U.S. states, marking a significant expansion into the U.S. hemp-derived THC beverage market.

The platform debuts with a diverse portfolio of hemp-derived THC beverages, including Sparkling Juices and Sparkling Lemonades in various pack sizes and THC dosages. A new line of hemp-derived THC sodas called Fetch is planned for launch later this summer. The company has already secured listings with major retail chains like Total Wine & More and Top Ten Liquors.

The U.S. hemp-derived THC beverage market has exceeded $1 billion in retail sales and is projected to reach $4 billion by 2028. This expansion represents a new revenue stream for Organigram, building on its successful track record and #1 market share position in Canada.

Organigram Global (NASDAQ: OGI) (TSX: OGI) announced that CEO Beena Goldenberg will retire at the end of the fiscal year on September 30, 2025. Under her leadership since 2021, Organigram transformed from an $80M revenue company to Canada's #1 cannabis company by market share, achieving over $250M in net revenue. Key accomplishments include doubling cultivation capacity in Moncton, securing leading positions in vapes, hash, and pre-rolls through three strategic acquisitions, and expanding internationally into Germany, UK, and Australia.

The company's Q2 FY2025 results showed a 74% year-over-year increase in net revenue. The recent acquisition of Collective Project in April 2025 marked Organigram's first revenue from the U.S. market. The Board will initiate a comprehensive CEO selection process to ensure continued growth and innovation leadership.

Organigram (NASDAQ: OGI) reported record Q2 Fiscal 2025 results, with gross revenue up 79% to $102.8 million and net revenue increasing 74% to $65.6 million. The company achieved net income of $42.5 million and Adjusted EBITDA of $4.9 million, compared to a loss in the previous year. International revenue grew 177% to $6.1 million. The company maintains a strong cash position of $83.4 million with negligible debt. Organigram holds #1 market share position in Canada across multiple categories including vapes, pre-rolls, and hash. The Motif integration is now expected to deliver $15 million in annual cost synergies, up from the original $10 million estimate. The company also acquired Collective Project, entering the U.S. and Canadian beverage categories with distribution in 10 states and six provinces.

Organigram Global Inc. (NASDAQ: OGI) has achieved significant recognition at the 2025 High Spirits Awards for its recently acquired brand, Collective Project. The company's hemp-derived THC beverages won a gold medal for Blood Orange, Yuzu & Vanilla and a platinum medal for Mango, Pineapple & Coconut flavors.

The products, which feature real fruit juice and are inspired by the global art community, are currently available across multiple U.S. states including Minnesota, Florida, Texas, and several others, with distribution through major retailers like Top Ten Liquors and Total Wine & More. Organigram plans to launch an eCommerce website in the coming weeks to support brand expansion.

This recognition comes shortly after Organigram's acquisition of Collective Project, validating the company's strategy to grow in the U.S. cannabis beverage market.

Organigram Global (NASDAQ: OGI) (TSX: OGI) has been awarded the "Exporter of the Year" at the 2025 New Brunswick Export Awards by Opportunities New Brunswick. The company, which is Canada's #1 cannabis company by market share, has demonstrated significant international growth with exports to Germany, the UK, and Australia.

Key achievements include:

• $50 million in international cannabis shipped sales since 2020
• $885 million in total shipped sales
• 725+ employees at Moncton facility
• Nearly $500 million invested in site development
• $34 million spent with local vendors
• $4 million investment in new substation with NB Power

As New Brunswick's fourth-largest private-sector employer, Organigram aims to position Canada to capture a share of the estimated $140 billion global cannabis market through federal engagement and a national cannabis export strategy.

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), currently holding the position of Canada's #1 cannabis company by market share, has scheduled its second quarter fiscal 2025 earnings release for Monday, May 12, 2025, before the market opens. The earnings will cover the period ended March 31, 2025.

The company will host a conference call at 8:00 am Eastern Time on the same day to discuss the results. Interested participants can register for the call through the provided link, with registration recommended at least 10 minutes before the call starts. A webcast replay will be available within 24 hours after the call and will remain accessible for 90 days on Organigram's investor relations website.